Respiratory syncytial virus (RSV) is one of the leading causes of respiratory tract infections in young children. While for some it can cause the common cold, for others, it may lead to more severe infection. Children under 1 year of age, individuals with underlying medical conditions (e.g. chronic cardiac and lung disease), the older population and immunocompromised people are more likely to experience serious disease and hospitalisation.
MVEC has recently updated its RSV reference page to include information about the newly approved AREXVY vaccine and with more detail on RSV symptoms, epidemiology and prevention.